Skip to main content
Premium Trial:

Request an Annual Quote

New Products: GeneDx's SCID Panel

Premium

GeneDx has launched its Comprehensive Severe Combined Immunodeficiency, or SCID, panel, which uses next-gen sequencing to screen 18 genes associated with SCID disorders.

Additionally, two sub-panels that target a subset of the 18 genes are available, including the B+ SCID sub-panel that targets 10 genes associated with SCID disorders that display a B+ lymphocyte profile, and the B- SCID sub-panel that targets eight genes associated with the B- lymphocyte profile.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.